Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/13/2026 | Q4 | $12.3B | -- | -- | $0.54 | -- |
| 11/05/2025 | Q3 | $12.4B | $11.6B | $0.55 | $0.38 | $0.18 |
| 08/08/2025 | Q2 | $12.9B | $10.7B | $0.23 | $0.33 | -$0.10 |
| 05/09/2025 | Q1 | $13.3B | $12B | $0.49 | $0.45 | $0.04 |
| 02/07/2025 | Q4 | $13.8B | $12.4B | -$0.04 | $0.42 | -$0.46 |
| 11/08/2024 | Q3 | $13.1B | $12.5B | $0.22 | $0.31 | -$0.08 |
| 08/02/2024 | Q2 | $12.8B | $12.8B | $0.26 | $0.32 | -$0.07 |
| 05/03/2024 | Q1 | $13B | $12.2B | $0.29 | $0.39 | -$0.10 |
| 02/09/2024 | Q4 | $13.4B | $12.7B | $0.35 | $0.35 | $0.00 |
| 11/01/2023 | Q3 | -- | $12.2B | $0.20 | -- | -- |
| 08/02/2023 | Q2 | -- | $11.5B | $0.33 | -- | -- |
| 05/05/2023 | Q1 | -- | $12.3B | $0.52 | -- | -- |
| 02/08/2023 | Q4 | -- | $12.9B | $0.30 | -- | -- |
| 11/02/2022 | Q3 | -- | $14B | $0.48 | -- | -- |
| 08/03/2022 | Q2 | -- | $16.3B | $0.22 | -- | -- |
| 05/04/2022 | Q1 | -- | $13.9B | $0.19 | -- | -- |
| 02/09/2022 | Q4 | -- | $12.8B | $0.56 | -- | -- |
| 11/02/2021 | Q3 | -- | $11B | -$0.15 | -- | -- |
| 08/03/2021 | Q2 | -- | $10.2B | -$0.37 | -- | -- |
| 05/04/2021 | Q1 | -- | $8.7B | $0.51 | -- | -- |
| 02/09/2021 | Q4 | -- | $6.2B | -$0.11 | -- | -- |
| 11/02/2020 | Q3 | -- | $5.9B | $0.13 | -- | -- |
| 08/04/2020 | Q2 | -- | $3.3B | $0.13 | -- | -- |
| 05/05/2020 | Q1 | -- | $8.1B | -$3.98 | -- | -- |
| 02/04/2020 | Q4 | -- | $9.2B | $0.35 | -- | -- |
| 11/05/2019 | Q3 | -- | $7.7B | $0.55 | -- | -- |
| 08/06/2019 | Q2 | -- | $8.2B | $0.54 | -- | -- |
| 05/07/2019 | Q1 | -- | $8.2B | $1.20 | -- | -- |
| 02/05/2019 | Q4 | -- | $8.2B | $1.38 | -- | -- |
| 11/06/2018 | Q3 | -- | $8.8B | $0.87 | -- | -- |
| 08/07/2018 | Q2 | -- | $8.4B | $0.07 | -- | -- |
| 05/08/2018 | Q1 | -- | $8.4B | $0.33 | -- | -- |
| 02/06/2018 | Q4 | -- | $7.8B | $0.19 | -- | -- |
| 11/06/2017 | Q3 | -- | $6.1B | -$0.01 | -- | -- |
| 08/08/2017 | Q2 | -- | $6B | $0.20 | -- | -- |
| 05/08/2017 | Q1 | -- | $6.6B | $0.58 | -- | -- |
| 02/07/2017 | Q4 | -- | $6.2B | $0.14 | -- | -- |
| 11/03/2016 | Q3 | -- | $5.2B | $0.40 | -- | -- |
| 08/02/2016 | Q2 | -- | $5.1B | -$0.20 | -- | -- |
| 05/04/2016 | Q1 | -- | $4.1B | $0.07 | -- | -- |
| 02/08/2016 | Q4 | -- | $5B | $0.24 | -- | -- |
Plains All American Pipeline LP reported $11.6B worth of top line sales in its most recent quarter.
Plains All American Pipeline LP announced earnings per share of $0.55 which represents a beat of analyst forecast a $0.38 per share.
Plains All American Pipeline LP reported $462M that represents $0.66 per share over the last quarter.
Plains All American Pipeline LP's earnings are forecast to grow from $0.73 per share to $1.45 per share next year representing an increase of 142.83%.
Plains All American Pipeline LP's next earnings date is February 13, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.